secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2025-11-13T23:59:59+00:00
Accession:  0001493152-25-022185
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
LLM model:  deepseek-v4-flash:cloud@v2

Regen BioPharma issues 23.68M common shares for cash and debt conversion in Oct-Nov 2025
--------------------------------------------------------------------------------

- Oct 8, 2025: issued 6.8M shares for $68,000 cash.
- Oct 27, 2025: issued 3.5M shares for $35,000 cash, and 4.5M shares to satisfy $30,204 debt principal plus $13,536 accrued interest.
- Oct 28, 2025: issued 7.1M shares for $71,000 cash.
- Nov 10, 2025: issued 1.78M shares for $17,800 cash under Tier 2 Reg A offering.
- All shares sold directly by management with no underwriter or commission.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000149315225022185/0001493152-25-022185-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000149315225022185/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-022185

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer